Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-02T11:42:23.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” and links to related updates and FAQs.
    Difference
    0.2%
    Check dated 2026-10-26T11:09:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-19T12:11:06.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-12T14:24:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new revision of the record in the History section.
    Difference
    0.0%
    Check dated 2026-09-21T20:35:38.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a small update to the page's revision metadata and does not alter the visible trial information.
    Difference
    0.0%
    Check dated 2026-08-31T17:33:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.